-
Neovasc Responds To FDA Not-Approvable Letter Regarding Neovasc Reducer
[ad_1] VANCOUVER and MINNEAPOLIS – (NewMediaWire) – January 15, 2021 – Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq, TSX: NVCN) announced…
Read More » -
BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders
[ad_1] Anaheim, CA – (NewMediaWire) – January 15, 2021 – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of…
Read More » -
News
Tauriga Sciences Inc. Completes Payment for the Entirety of its Initial Production Run of its Caffeine Infused Version of Tauri-Gum
[ad_1] This Caffeine Version of Tauri-Gum™ is the 7th SKU of this Fast-Growing Product Line NEW YORK, NY – (NewMediaWire)…
Read More » -
Sentaida Tire Company Ltd. Announces Acquisition of GivBux Global Partners, Inc. and Change of Name to GivBux, Inc.
[ad_1] Newport Beach, CA – (NewMediaWire) – January 14, 2021 – Sentaida Tire Company, Ltd., (OTC Markets: SDTC) announced today…
Read More » -
MediXall Group Issues January 2021 Shareholder Update Letter
[ad_1] Fort Lauderdale, FL – (NewMediaWire) – January 14, 2021 – MediXall Group, Inc. (OTCQB: MDXL), a healthcare technology company…
Read More »